A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Florida Board of Education approves new Black history standards that critics call 'a big step backward'
Why Montana's TikTok ban may not work
White House Tells Debt-Limit Negotiators to Protect Gains on Drug Prices, Climate
Duality Featured on Fast Company’s 2023 World Changing Ideas List
Broadcom’s Earnings Will Test Whether AI Euphoria Is Fading
JPMorgan Expands $7 Billion ETF Platform With Funds Tied to PAB
The Bond Selloff Is Gathering Pace. Why the Fed Isn’t Intervening.
Cutting social media use to 30 minutes per day found to significantly reduce anxiety and loneliness